Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2018

Scognamiglio T, Chen Y-. Beyond the Percentages of PD-L1-Positive Tumor Cells: Induced Versus Constitutive PD-L1 Expression in Primary and Metastatic Head and Neck Squamous Cell Carcinoma. Head Neck Pathol. 2018;12(2):221-229.

Galassi TV, Jena PV, Shah J, Ao G, Molitor E, Bram Y, et al. An optical nanoreporter of endolysosomal lipid accumulation reveals enduring effects of diet on hepatic macrophages in vivo. Sci Transl Med. 2018;10(461).

Sederdahl BK, Yi J, Jerris RC, Gillespie SE, Westblade LF, Kraft CS, et al. Trends in rotavirus from 2001 to 2015 in two paediatric hospitals in Atlanta, Georgia. Epidemiol Infect. 2018;146(4):465-467.

Katz LM, Hielscher T, Liechty B, Silverman J, Zagzag D, Sen R, et al. Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence. Acta Neuropathol. 2018;135(6):955-963.

Hung PJ, Johnson B, Chen B-, Byrum AK, Bredemeyer AL, Yewdell WT, et al. MRI Is a DNA Damage Response Adaptor during Classical Non-homologous End Joining. Mol Cell. 2018;71(2):332-342.e8.

Chiaretti S, Messina M, Grammatico S, Piciocchi A, Fedullo AL, Di Giacomo F, et al. Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications. Br J Haematol. 2018;181(5):642-652.

Huang J, Duran A, Reina-Campos M, Valencia T, Castilla EA, Müller TD, et al. Adipocyte p62/SQSTM1 Suppresses Tumorigenesis through Opposite Regulations of Metabolism in Adipose Tissue and Tumor. Cancer Cell. 2018;33(4):770-784.e6.

DeSimone RA, Nowak MD, Lo DT, Crowley KM, Parra P, Cushing MM, et al. Logistical and safety implications of temperature-based acceptance of returned red blood cell units. Transfusion. 2018;58(6):1500-1505.

Schreiber K, Breen K, Parmar K, Rand JH, Wu X-, Hunt BJ. The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies. Rheumatology (Oxford). 2018;57(1):120-124.

Gordon JK, Martyanov V, Franks JM, Bernstein EJ, Szymonifka J, Magro C, et al. Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial. Arthritis Rheumatol. 2018;70(2):308-316.